Concerns Mount Over Late Prostate Cancer Diagnosis of Former President Joe Biden
- Victor Nwoko
- May 19
- 3 min read
Medical experts and political observers are raising serious questions about how former U.S. President Joe Biden was diagnosed with an aggressive, late-stage form of prostate cancer despite having access to the best healthcare in the world. The 82-year-old's office confirmed on Sunday, May 18, 2025, that Biden’s cancer has metastasized to his bones, and his family is currently reviewing treatment options.
Biden’s cancer was classified as a Gleason score of 9 and a Grade Group of 5—indicators of a highly aggressive and advanced stage of the disease. The diagnosis reportedly came just days after doctors discovered a small nodule on his prostate.
The news has prompted widespread sympathy from across the political spectrum. Former President Donald Trump and First Lady Melania expressed wishes for a swift recovery, while other public figures and medical professionals began questioning the timing and transparency surrounding Biden’s diagnosis.
Dr. Steven Quay, a physician, publicly called prostate cancer “the easiest cancer to diagnose when it first starts,” pointing out that it typically requires years to progress to bone metastasis. His comments fueled speculation about whether Biden had been aware of the condition during his presidency. Dr. Howie Forman of Yale University echoed the disbelief, saying it is “inconceivable” that such aggressive cancer was not detected earlier through standard PSA testing, which is routinely advised for men over 50.
Forman questioned whether Biden had undergone proper screenings in the last decade and expressed confusion over how such a high-profile individual, with constant access to elite care, could have reached such an advanced stage unnoticed. Fox News medical analyst Dr. Marc Siegel added to the concerns, saying he was "taken aback" by the advanced state of Biden's cancer, considering the standard practice of PSA testing and MRI follow-ups for elevated results. He noted that Biden’s symptoms, including urinary issues, indicated the disease had already progressed significantly.
Dr. David Shusterman, a New York-based urologist, described the diagnosis as “unheard of,” claiming that such an aggressive form of cancer would have taken years to reach this stage. He concluded there was “definitely evidence” that the cancer had been present long before the diagnosis was made public.
Speculation has intensified online and within political circles. Donald Trump Jr. and several conservative commentators suggested a potential cover-up, questioning how First Lady Dr. Jill Biden and White House physicians might have missed the warning signs. Commentators like Benny Johnson and Tim Young argued that the administration may have deliberately hidden the former president’s condition to maintain political power, citing a 2024 medical report that declared Biden “fit to serve.”
Further allegations of concealment have been amplified by the forthcoming release of Original Sin: President Biden’s Decline, Its Cover-Up, and His Disastrous Choice to Run Again by CNN’s Jake Tapper and Axios' Alex Thompson. The book details how Biden’s advisers allegedly tried to manage the public perception of his health, even considering the use of a wheelchair while planning to obscure it until after the 2024 election.
Biden’s medical history includes brain aneurysms in 1988, lesion removal in 2023, and non-melanoma skin cancer treatments before his presidency. Despite this history, his long-time physician, Dr. Kevin O’Connor, had publicly stated in February 2024 that Biden was “fit to serve” following a routine physical at Walter Reed Medical Center.
Critics are now calling for investigations into Biden’s medical evaluations, with some demanding that Dr. O’Connor be held accountable. There are concerns that the delayed announcement of Biden's diagnosis may have affected the 2024 presidential race, as he withdrew only after a poor debate performance and mounting pressure, allowing then-Vice President Kamala Harris to step in—ultimately losing to Trump.
Biden is expected to undergo hormone therapy, potentially using medications like Lupron or Casodex to suppress testosterone, which fuels prostate cancer growth. However, such treatments often lead to fatigue and may become ineffective as the disease adapts. In those cases, secondary treatments including chemotherapy, targeted drugs, or radiopharmaceuticals may be introduced.
Despite the controversy, many current and former officials have expressed support for Biden. Former President Barack Obama praised Biden’s long-standing commitment to cancer research, referencing his Cancer Moonshot initiative. Vice President Harris and her husband expressed optimism for a full recovery. Even political opponents such as Marjorie Taylor Greene and Meghan McCain offered words of sympathy, putting aside partisanship to acknowledge the severity of the diagnosis.
As the former president begins his fight against metastatic prostate cancer, scrutiny continues over the timeline of his diagnosis, the transparency of his medical records, and the implications for public trust in presidential health disclosures.
Comments